Key Points - Quantum biopharma Quantum provides corporate update with strong revenue growth and commercialization momentum - QUBT and QNT stand out in the quantum stock market with over 75% upside - BMO Capital analyst Harsh Kumar recommends buying D-Wave Quantum stock, even though Rigetti stock is rising - WiMi introduces a cutting-edge quantum machine...
Viveve Medical, Inc. (VIVE) confirmed earnings release on August 21, 2026, for the quarter ending June...
eFFECTOR Therapeutics, Inc. (EFTR) confirmed earnings release on August 21, 2026, for the quarter ending March...
COMSovereign Holding Corp. (COMS) confirmed earnings release on August 21, 2026, for the quarter ending June...
Imperial Petroleum Inc. (IMPPP) confirmed earnings release on August 21, 2026, Before the market for the...
from H.C. Wainwright issued a price target of $2.00 for COCH on 2026-08-21 10:02:41.The adjusted price target was set to $2.00.At the time of the announcement, COCH was trading at...
from Roth Capital issued a price target of $3.50 for MRT on 2026-08-20 20:18:04.The adjusted price target was set to $3.50.At the time of the announcement, MRT was trading at...
Mark Palmer from Coker Palmer issued a price target of $32.00 for ASST on 2026-08-20 13:16:00.The adjusted price target was set to $32.00.At the time of the announcement, ASST was...
from Craig-Hallum issued a price target of $68.00 for QNCX on 2026-08-20 11:20:14.The adjusted price target was set to $68.00.At the time of the announcement, QNCX was trading at $34.57.The...
from Roth Capital issued a price target of $7.00 for CRVO on 2026-08-20 10:39:45.The adjusted price target was set to $7.00.At the time of the announcement, CRVO was trading at...
In a tale of resilience and ambition, the company reported total revenues of 3,547,399, driven by steady premium earnings despite rising operating expenses. Management's focus on new operating units in...
In a dynamic financial landscape, the company reported total revenues of 3,547,399, driven by insurance commissions and strategic initiatives. Operating expenses rose to 3,008,793, yet efficient cost management improved the...
In a landscape marked by competition and uncertainty, the company reported total revenues of 3,547,399, driven by insurance commissions and strategic initiatives. Operating expenses rose to 3,008,793, yet the expense...
In the first quarter of 2025, NextEra Energy made significant strides with $238 million in new investments, boosting total revenues to $5,731 million. Operating expenses saw a notable decline, while...
In a landscape of fluctuating revenues and complex operating expenses, KKR navigates its financial journey with strategic investments and a commitment to transparency. Management emphasizes the importance of timely decision-making...
